Global Biosimilar Drug Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

Global Biosimilar Drug Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

Table of Contents
1 Study Coverage
1.1 Biosimilar Drug Product Introduction
1.2 Market by Type
1.2.1 Global Biosimilar Drug Market Size Growth Rate by Type
1.2.2 Injection
1.2.3 Tablets
1.2.4 Other Types
1.3 Market by Application
1.3.1 Global Biosimilar Drug Market Size Growth Rate by Application
1.3.2 Ankylosing Spondylitis
1.3.3 Tumor
1.3.4 Rheumatoid Arthrtis
1.3.5 Cardiovascular
1.3.6 Other Application
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Biosimilar Drug Market Size Estimates and Forecasts
2.1.1 Global Biosimilar Drug Revenue 2016-2027
2.1.2 Global Biosimilar Drug Sales 2016-2027
2.2 Biosimilar Drug Market Size by Region: 2021 Versus 2027
2.3 Biosimilar Drug Sales by Region (2016-2027)
2.3.1 Global Biosimilar Drug Sales by Region: 2016-2021
2.3.2 Global Biosimilar Drug Sales Forecast by Region (2022-2027)
2.3.3 Global Biosimilar Drug Sales Market Share by Region (2016-2027)
2.4 Biosimilar Drug Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Biosimilar Drug Revenue by Region: 2016-2021
2.4.2 Global Biosimilar Drug Revenue Forecast by Region (2022-2027)
2.4.3 Global Biosimilar Drug Revenue Market Share by Region (2016-2027)
3 Global Biosimilar Drug by Manufacturers
3.1 Global Top Biosimilar Drug Manufacturers by Sales
3.1.1 Global Biosimilar Drug Sales by Manufacturer (2016-2021)
3.1.2 Global Biosimilar Drug Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Biosimilar Drug Manufacturers by Revenue
3.2.1 Global Biosimilar Drug Revenue by Manufacturer (2016-2021)
3.2.2 Global Biosimilar Drug Revenue Share by Manufacturer (2016-2021)
3.3 Global Biosimilar Drug Price by Manufacturer (2016-2021)
3.4 Competitive Landscape
3.4.1 Key Biosimilar Drug Manufacturers Covered: Ranking by Revenue
3.4.2 Global Biosimilar Drug Market Concentration Ratio (CR5 and HHI) & (2016-2021)
3.4.3 Global Biosimilar Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Biosimilar Drug Manufacturing Base Distribution, Product Type
3.5.1 Biosimilar Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Biosimilar Drug Product Type
3.5.3 Date of International Manufacturers Enter into Biosimilar Drug Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 CP Guojian Pharma
4.1.1 CP Guojian Pharma Corporation Information
4.1.2 CP Guojian Pharma Description, Business Overview
4.1.3 CP Guojian Pharma Biosimilar Drug Products Offered
4.1.4 CP Guojian Pharma Biosimilar Drug Sales, Revenue and Gross Margin (2016-2021)
4.1.5 CP Guojian Pharma Biosimilar Drug Revenue by Product
4.1.6 CP Guojian Pharma Biosimilar Drug Revenue by Application
4.1.7 CP Guojian Pharma Biosimilar Drug Revenue by Geographic Area
4.1.8 CP Guojian Pharma Biosimilar Drug Revenue by Sales Channel
4.1.9 CP Guojian Pharma Recent Development
4.2 Biotech Pharma
4.2.1 Biotech Pharma Corporation Information
4.2.2 Biotech Pharma Description, Business Overview
4.2.3 Biotech Pharma Biosimilar Drug Products Offered
4.2.4 Biotech Pharma Biosimilar Drug Sales, Revenue and Gross Margin (2016-2021)
4.2.5 Biotech Pharma Biosimilar Drug Revenue by Product
4.2.6 Biotech Pharma Biosimilar Drug Revenue by Application
4.2.7 Biotech Pharma Biosimilar Drug Revenue by Geographic Area
4.2.8 Biotech Pharma Biosimilar Drug Revenue by Sales Channel
4.2.9 Biotech Pharma Recent Development
4.3 Celgen Pharma
4.3.1 Celgen Pharma Corporation Information
4.3.2 Celgen Pharma Description, Business Overview
4.3.3 Celgen Pharma Biosimilar Drug Products Offered
4.3.4 Celgen Pharma Biosimilar Drug Sales, Revenue and Gross Margin (2016-2021)
4.3.5 Celgen Pharma Biosimilar Drug Revenue by Product
4.3.6 Celgen Pharma Biosimilar Drug Revenue by Application
4.3.7 Celgen Pharma Biosimilar Drug Revenue by Geographic Area
4.3.8 Celgen Pharma Biosimilar Drug Revenue by Sales Channel
4.3.9 Celgen Pharma Recent Development
4.4 Henlius
4.4.1 Henlius Corporation Information
4.4.2 Henlius Description, Business Overview
4.4.3 Henlius Biosimilar Drug Products Offered
4.4.4 Henlius Biosimilar Drug Sales, Revenue and Gross Margin (2016-2021)
4.4.5 Henlius Biosimilar Drug Revenue by Product
4.4.6 Henlius Biosimilar Drug Revenue by Application
4.4.7 Henlius Biosimilar Drug Revenue by Geographic Area
4.4.8 Henlius Biosimilar Drug Revenue by Sales Channel
4.4.9 Henlius Recent Development
4.5 Amgen
4.5.1 Amgen Corporation Information
4.5.2 Amgen Description, Business Overview
4.5.3 Amgen Biosimilar Drug Products Offered
4.5.4 Amgen Biosimilar Drug Sales, Revenue and Gross Margin (2016-2021)
4.5.5 Amgen Biosimilar Drug Revenue by Product
4.5.6 Amgen Biosimilar Drug Revenue by Application
4.5.7 Amgen Biosimilar Drug Revenue by Geographic Area
4.5.8 Amgen Biosimilar Drug Revenue by Sales Channel
4.5.9 Amgen Recent Development
4.6 Eli Lilly
4.6.1 Eli Lilly Corporation Information
4.6.2 Eli Lilly Description, Business Overview
4.6.3 Eli Lilly Biosimilar Drug Products Offered
4.6.4 Eli Lilly Biosimilar Drug Sales, Revenue and Gross Margin (2016-2021)
4.6.5 Eli Lilly Biosimilar Drug Revenue by Product
4.6.6 Eli Lilly Biosimilar Drug Revenue by Application
4.6.7 Eli Lilly Biosimilar Drug Revenue by Geographic Area
4.6.8 Eli Lilly Recent Development
4.7 Sandoz
4.7.1 Sandoz Corporation Information
4.7.2 Sandoz Description, Business Overview
4.7.3 Sandoz Biosimilar Drug Products Offered
4.7.4 Sandoz Biosimilar Drug Sales, Revenue and Gross Margin (2016-2021)
4.7.5 Sandoz Biosimilar Drug Revenue by Product
4.7.6 Sandoz Biosimilar Drug Revenue by Application
4.7.7 Sandoz Biosimilar Drug Revenue by Geographic Area
4.7.8 Sandoz Recent Development
4.8 Changchun High Tech
4.8.1 Changchun High Tech Corporation Information
4.8.2 Changchun High Tech Description, Business Overview
4.8.3 Changchun High Tech Biosimilar Drug Products Offered
4.8.4 Changchun High Tech Biosimilar Drug Sales, Revenue and Gross Margin (2016-2021)
4.8.5 Changchun High Tech Biosimilar Drug Revenue by Product
4.8.6 Changchun High Tech Biosimilar Drug Revenue by Application
4.8.7 Changchun High Tech Biosimilar Drug Revenue by Geographic Area
4.8.8 Changchun High Tech Recent Development
4.9 Innovent
4.9.1 Innovent Corporation Information
4.9.2 Innovent Description, Business Overview
4.9.3 Innovent Biosimilar Drug Products Offered
4.9.4 Innovent Biosimilar Drug Sales, Revenue and Gross Margin (2016-2021)
4.9.5 Innovent Biosimilar Drug Revenue by Product
4.9.6 Innovent Biosimilar Drug Revenue by Application
4.9.7 Innovent Biosimilar Drug Revenue by Geographic Area
4.9.8 Innovent Recent Development
5 Breakdown Data by Type
5.1 Global Biosimilar Drug Sales by Type (2016-2027)
5.1.1 Global Biosimilar Drug Sales by Type (2016-2021)
5.1.2 Global Biosimilar Drug Sales Forecast by Type (2022-2027)
5.1.3 Global Biosimilar Drug Sales Market Share by Type (2016-2027)
5.2 Global Biosimilar Drug Revenue Forecast by Type (2016-2027)
5.2.1 Global Biosimilar Drug Revenue by Type (2016-2021)
5.2.2 Global Biosimilar Drug Revenue Forecast by Type (2022-2027)
5.2.3 Global Biosimilar Drug Revenue Market Share by Type (2016-2027)
5.3 Biosimilar Drug Average Selling Price (ASP) by Type (2016-2027)
6 Breakdown Data by Application
6.1 Global Biosimilar Drug Sales by Application (2016-2027)
6.1.1 Global Biosimilar Drug Sales by Application (2016-2021)
6.1.2 Global Biosimilar Drug Sales Forecast by Application (2022-2027)
6.1.3 Global Biosimilar Drug Sales Market Share by Application (2016-2027)
6.2 Global Biosimilar Drug Revenue Forecast by Application (2016-2027)
6.2.1 Global Biosimilar Drug Revenue by Application (2016-2021)
6.2.2 Global Biosimilar Drug Revenue Forecast by Application (2022-2027)
6.2.3 Global Biosimilar Drug Revenue Market Share by Application (2016-2027)
6.3 Biosimilar Drug Average Selling Price (ASP) by Application (2016-2027)
7 North America
7.1 North America Biosimilar Drug Market Size YoY Growth 2016-2027
7.2 North America Biosimilar Drug Market Facts & Figures by Country
7.2.1 North America Biosimilar Drug Sales by Country (2016-2027)
7.2.2 North America Biosimilar Drug Revenue by Country (2016-2027)
7.3 North America Biosimilar Drug Sales by Type
7.4 North America Biosimilar Drug Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Biosimilar Drug Market Size YoY Growth 2016-2027
8.2 Asia-Pacific Biosimilar Drug Market Facts & Figures by Region
8.2.1 Asia-Pacific Biosimilar Drug Sales by Region (2016-2027)
8.2.2 Asia-Pacific Biosimilar Drug Revenue by Region (2016-2027)
8.3 Asia-Pacific Biosimilar Drug Sales by Type
8.4 Asia-Pacific Biosimilar Drug Sales by Application
9 Europe
9.1 Europe Biosimilar Drug Market Size YoY Growth 2016-2027
9.2 Europe Biosimilar Drug Market Facts & Figures by Country
9.2.1 Europe Biosimilar Drug Sales by Country (2016-2027)
9.2.2 Europe Biosimilar Drug Revenue by Country (2016-2027)
9.3 Europe Biosimilar Drug Sales by Type
9.4 Europe Biosimilar Drug Sales by Application
10 Latin America
10.1 Latin America Biosimilar Drug Market Size YoY Growth 2016-2027
10.2 Latin America Biosimilar Drug Market Facts & Figures by Country
10.2.1 Latin America Biosimilar Drug Sales by Country (2016-2027)
10.2.2 Latin America Biosimilar Drug Revenue by Country (2016-2027)
10.3 Latin America Biosimilar Drug Sales by Type
10.4 Latin America Biosimilar Drug Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Biosimilar Drug Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Biosimilar Drug Market Facts & Figures by Country
11.2.1 Middle East and Africa Biosimilar Drug Sales by Country (2016-2027)
11.2.2 Middle East and Africa Biosimilar Drug Revenue by Country (2016-2027)
11.3 Middle East and Africa Biosimilar Drug Sales by Type
11.4 Middle East and Africa Biosimilar Drug Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Biosimilar Drug Supply Chain Analysis
12.2 Biosimilar Drug Key Raw Materials and Upstream Suppliers
12.3 Biosimilar Drug Clients Analysis
12.4 Biosimilar Drug Sales Channel and Sales Model Analysis
12.4.1 Biosimilar Drug Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Biosimilar Drug Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Biosimilar Drug Distributors
13 Market Dynamics
13.1 Biosimilar Drug Market Drivers
13.2 Biosimilar Drug Market Opportunities
13.3 Biosimilar Drug Market Challenges
13.4 Biosimilar Drug Market Restraints
13.5 Porter's Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Biosimilar Drug Market Size Growth Rate by Type (US$ Million): 2021 VS 2027
Table 2. Major Manufacturers of Injection
Table 3. Major Manufacturers of Tablets
Table 4. Major Manufacturers of Other Types
Table 5. Global Biosimilar Drug Market Size Growth by Application (US$ Million): 2021 VS 2027
Table 6. Global Biosimilar Drug Market Size by Region (US$ Million): 2021 VS 2027
Table 7. Global Biosimilar Drug Sales by Region (2016-2021) & (K Dose)
Table 8. Global Biosimilar Drug Sales Forecast by Region (2022-2027) & (K Dose)
Table 9. Global Biosimilar Drug Revenue by Region (2016-2021) & (US$ Million)
Table 10. Global Biosimilar Drug Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 11. Global Biosimilar Drug Sales by Manufacturer (2016-2021) & (K Dose)
Table 12. Global Biosimilar Drug Sales Share by Manufacturer (2016-2021)
Table 13. Biosimilar Drug Revenue by Manufacturer (2016-2021) & (US$ Million)
Table 14. Biosimilar Drug Revenue Share by Manufacturer (2016-2021)
Table 15. Key Manufacturers Biosimilar Drug Price (2016-2021) & (USD/Dose)
Table 16. Ranking of Global Top Biosimilar Drug Manufacturers by Revenue (US$ Million) in 2020
Table 17. Global Biosimilar Drug Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 18. Global Biosimilar Drug by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Biosimilar Drug as of 2020)
Table 19. Biosimilar Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Biosimilar Drug Product Type
Table 21. Date of International Manufacturers Enter into Biosimilar Drug Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. CP Guojian Pharma Corporation Information
Table 24. CP Guojian Pharma Description and Business Overview
Table 25. CP Guojian Pharma Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 26. CP Guojian Pharma Biosimilar Drug Product
Table 27. CP Guojian Pharma Biosimilar Drug Revenue (US$ Million) and Market Share by Product
Table 28. CP Guojian Pharma Biosimilar Drug Revenue (US$ Million) and Market Share by Application
Table 29. CP Guojian Pharma Biosimilar Drug Revenue (US$ Million) and Market Share by Geographic Area
Table 30. CP Guojian Pharma Biosimilar Drug Revenue (US$ Million) and Market Share by Sales Channel
Table 31. CP Guojian Pharma Recent Development
Table 32. Biotech Pharma Corporation Information
Table 33. Biotech Pharma Description and Business Overview
Table 34. Biotech Pharma Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 35. Biotech Pharma Biosimilar Drug Product
Table 36. Biotech Pharma Biosimilar Drug Revenue (US$ Million) and Market Share by Product
Table 37. Biotech Pharma Biosimilar Drug Revenue (US$ Million) and Market Share by Application
Table 38. Biotech Pharma Biosimilar Drug Revenue (US$ Million) and Market Share by Geographic Area
Table 39. Biotech Pharma Biosimilar Drug Revenue (US$ Million) and Market Share by Sales Channel
Table 40. Biotech Pharma Recent Development
Table 41. Celgen Pharma Corporation Information
Table 42. Celgen Pharma Description and Business Overview
Table 43. Celgen Pharma Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 44. Celgen Pharma Biosimilar Drug Product
Table 45. Celgen Pharma Biosimilar Drug Revenue (US$ Million) and Market Share by Product
Table 46. Celgen Pharma Biosimilar Drug Revenue (US$ Million) and Market Share by Application
Table 47. Celgen Pharma Biosimilar Drug Revenue (US$ Million) and Market Share by Geographic Area
Table 48. Celgen Pharma Biosimilar Drug Revenue (US$ Million) and Market Share by Sales Channel
Table 49. Celgen Pharma Recent Development
Table 50. Henlius Corporation Information
Table 51. Henlius Description and Business Overview
Table 52. Henlius Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 53. Henlius Biosimilar Drug Product
Table 54. Henlius Biosimilar Drug Revenue (US$ Million) and Market Share by Product
Table 55. Henlius Biosimilar Drug Revenue (US$ Million) and Market Share by Application
Table 56. Henlius Biosimilar Drug Revenue (US$ Million) and Market Share by Geographic Area
Table 57. Henlius Biosimilar Drug Revenue (US$ Million) and Market Share by Sales Channel
Table 58. Henlius Recent Development
Table 59. Amgen Corporation Information
Table 60. Amgen Description and Business Overview
Table 61. Amgen Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 62. Amgen Biosimilar Drug Product
Table 63. Amgen Biosimilar Drug Revenue (US$ Million) and Market Share by Product
Table 64. Amgen Biosimilar Drug Revenue (US$ Million) and Market Share by Application
Table 65. Amgen Biosimilar Drug Revenue (US$ Million) and Market Share by Geographic Area
Table 66. Amgen Biosimilar Drug Revenue (US$ Million) and Market Share by Sales Channel
Table 67. Amgen Recent Development
Table 68. Eli Lilly Corporation Information
Table 69. Eli Lilly Description and Business Overview
Table 70. Eli Lilly Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 71. Eli Lilly Biosimilar Drug Product
Table 72. Eli Lilly Biosimilar Drug Revenue (US$ Million) and Market Share by Product
Table 73. Eli Lilly Biosimilar Drug Revenue (US$ Million) and Market Share by Application
Table 74. Eli Lilly Biosimilar Drug Revenue (US$ Million) and Market Share by Geographic Area
Table 75. Eli Lilly Recent Development
Table 76. Sandoz Corporation Information
Table 77. Sandoz Description and Business Overview
Table 78. Sandoz Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 79. Sandoz Biosimilar Drug Product
Table 80. Sandoz Biosimilar Drug Revenue (US$ Million) and Market Share by Product
Table 81. Sandoz Biosimilar Drug Revenue (US$ Million) and Market Share by Application
Table 82. Sandoz Biosimilar Drug Revenue (US$ Million) and Market Share by Geographic Area
Table 83. Sandoz Recent Development
Table 84. Changchun High Tech Corporation Information
Table 85. Changchun High Tech Description and Business Overview
Table 86. Changchun High Tech Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 87. Changchun High Tech Biosimilar Drug Product
Table 88. Changchun High Tech Biosimilar Drug Revenue (US$ Million) and Market Share by Product
Table 89. Changchun High Tech Biosimilar Drug Revenue (US$ Million) and Market Share by Application
Table 90. Changchun High Tech Biosimilar Drug Revenue (US$ Million) and Market Share by Geographic Area
Table 91. Changchun High Tech Recent Development
Table 92. Innovent Corporation Information
Table 93. Innovent Description and Business Overview
Table 94. Innovent Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 95. Innovent Biosimilar Drug Product
Table 96. Innovent Biosimilar Drug Revenue (US$ Million) and Market Share by Product
Table 97. Innovent Biosimilar Drug Revenue (US$ Million) and Market Share by Application
Table 98. Innovent Biosimilar Drug Revenue (US$ Million) and Market Share by Geographic Area
Table 99. Innovent Recent Development
Table 100. Global Biosimilar Drug Sales by Type (2016-2021) & (K Dose)
Table 101. Global Biosimilar Drug Sales Forecast by Type (2022-2027) & (K Dose)
Table 102. Global Biosimilar Drug Revenue by Type (2016-2021) & (US$ Million)
Table 103. Global Biosimilar Drug Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 104. Global Biosimilar Drug Sales by Application (2016-2021) & (K Dose)
Table 105. Global Biosimilar Drug Sales Forecast by Application (2022-2027) & (K Dose)
Table 106. Global Biosimilar Drug Revenue by Application (2016-2021) & (US$ Million)
Table 107. Global Biosimilar Drug Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 108. North America Biosimilar Drug Sales by Country (2016-2021) & (K Dose)
Table 109. North America Biosimilar Drug Sales by Country (2022-2027) & (K Dose)
Table 110. North America Biosimilar Drug Revenue by Country (2016-2021) & (US$ Million)
Table 111. North America Biosimilar Drug Revenue by Country (2022-2027) & (US$ Million)
Table 112. North America Biosimilar Drug Sales by Type (2016-2021) & (K Dose)
Table 113. North America Biosimilar Drug Sales by Application (2016-2021) & (K Dose)
Table 114. Asia-Pacific Biosimilar Drug Sales by Region (2016-2021) & (K Dose)
Table 115. Asia-Pacific Biosimilar Drug Sales by Region (2022-2027) & (K Dose)
Table 116. Asia-Pacific Biosimilar Drug Revenue by Region (2016-2027) & (US$ Million)
Table 117. Asia-Pacific Biosimilar Drug Revenue by Region (2022-2027) & (US$ Million)
Table 118. Asia-Pacific Biosimilar Drug Sales by Type (2016-2021) & (K Dose)
Table 119. Asia-Pacific Biosimilar Drug Sales by Application (2016-2021) & (K Dose)
Table 120. Europe Biosimilar Drug Sales by Country (2016-2021) & (K Dose)
Table 121. Europe Biosimilar Drug Sales by Country (2022-2027) & (K Dose)
Table 122. Europe Biosimilar Drug Revenue by Country (2016-2021) & (US$ Million)
Table 123. Europe Biosimilar Drug Revenue by Country (2022-2027) & (US$ Million)
Table 124. Europe Biosimilar Drug Sales by Type (2016-2021) & (K Dose)
Table 125. Europe Biosimilar Drug Sales by Application (2016-2021) & (K Dose)
Table 126. Latin America Biosimilar Drug Sales by Country (2016-2021) & (K Dose)
Table 127. Latin America Biosimilar Drug Sales by Country (2022-2027) & (K Dose)
Table 128. Latin America Biosimilar Drug Revenue by Country (2016-2021) & (US$ Million)
Table 129. Latin America Biosimilar Drug Revenue by Country (2022-2027) & (US$ Million)
Table 130. Latin America Biosimilar Drug Sales by Type (2016-2021) & (K Dose)
Table 131. Latin America Biosimilar Drug Sales by Application (2016-2021) & (K Dose)
Table 132. Middle East and Africa Biosimilar Drug Sales by Country (2016-2021) & (K Dose)
Table 133. Middle East and Africa Biosimilar Drug Sales by Country (2022-2027) & (K Dose)
Table 134. Middle East and Africa Biosimilar Drug Revenue by Country (2016-2021) & (US$ Million)
Table 135. Middle East and Africa Biosimilar Drug Revenue by Country (2022-2027) & (US$ Million)
Table 136. Middle East and Africa Biosimilar Drug Sales by Type (2016-2021) & (K Dose)
Table 137. Middle East and Africa Biosimilar Drug Sales by Application (2016-2021) & (K Dose)
Table 138. Biosimilar Drug Key Raw Materials, Industry Status and Trend
Table 139. Biosimilar Drug Key Raw Materials and Upstream Suppliers
Table 140. Biosimilar Drug Clients Status and Trend
Table 141. Biosimilar Drug Typical Clients
Table 142. Biosimilar Drug Distributors
Table 143. Key Drivers: Impact Analysis (2022-2027)
Table 144. Biosimilar Drug Market Drivers
Table 145. Biosimilar Drug Market Opportunities
Table 146. Biosimilar Drug Market Challenges
Table 147. Biosimilar Drug Market Restraints
Table 148. Biosimilar Drug Porter's Five Forces Analysis
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
List of Figures
Figure 1. Biosimilar Drug Product Picture
Figure 2. Global Biosimilar Drug Sales Market Share by Type in 2021 & 2027
Figure 3. Injection Product Picture
Figure 4. Tablets Product Picture
Figure 5. Other Types Product Picture
Figure 6. Global Biosimilar Drug Sales Market Share by Application in 2021 & 2027
Figure 7. Ankylosing Spondylitis Examples
Figure 8. Tumor Examples
Figure 9. Rheumatoid Arthrtis Examples
Figure 10. Cardiovascular Examples
Figure 11. Other Application Examples
Figure 12. Biosimilar Drug Report Years Considered
Figure 13. Global Biosimilar Drug Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Biosimilar Drug Market Size 2016-2027 (US$ Million)
Figure 15. Global Biosimilar Drug Sales 2016-2027 (K Units)
Figure 16. Global Biosimilar Drug Market Size Market Share by Region: 2021 Versus 2027
Figure 17. Global Biosimilar Drug Sales Market Share Forecast by Region (2016-2027)
Figure 18. Global Biosimilar Drug Revenue Market Share by Region (2016-2027)
Figure 19. Global Biosimilar Drug Sales Share by Manufacturer in 2020
Figure 20. Biosimilar Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 21. Global Biosimilar Drug Sales Market Share Forecast by Type (2016-2027)
Figure 22. Global Biosimilar Drug Revenue Market Share Forecast by Type (2016-2027)
Figure 23. Biosimilar Drug Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
Figure 24. Global Biosimilar Drug Sales Market Share Forecast by Application (2016-2027)
Figure 25. Global Biosimilar Drug Revenue Market Share Forecast by Application (2016-2027)
Figure 26. Biosimilar Drug Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
Figure 27. North America Biosimilar Drug Revenue 2016-2027 (US$ Million)
Figure 28. North America Biosimilar Drug Sales Market Share by Type (2016-2021)
Figure 29. North America Biosimilar Drug Sales Market Share by Application (2016-2021)
Figure 30. Asia-Pacific Biosimilar Drug Revenue 2016-2027 (US$ Million)
Figure 31. Asia-Pacific Biosimilar Drug Sales Market Share by Region (2016-2027)
Figure 32. Asia-Pacific Biosimilar Drug Revenue Market Share by Region (2016-2027)
Figure 33. Asia-Pacific Biosimilar Drug Sales Market Share by Type (2016-2021)
Figure 34. Asia-Pacific Biosimilar Drug Sales Market Share by Application (2016-2021)
Figure 35. Europe Biosimilar Drug Revenue Growth Rate 2016-2027 (US$ Million)
Figure 36. Europe Biosimilar Drug Sales Market Share by Country (2016-2027)
Figure 37. Europe Biosimilar Drug Revenue Market Share by Country (2016-2027)
Figure 38. Europe Biosimilar Drug Sales Market Share by Type (2016-2021)
Figure 39. Europe Biosimilar Drug Sales Market Share by Application (2016-2021)
Figure 40. Latin America Biosimilar Drug Revenue Growth Rate 2016-2027 (US$ Million)
Figure 41. Latin America Biosimilar Drug Sales Market Share by Country (2016-2027)
Figure 42. Latin America Biosimilar Drug Revenue Market Share by Country (2016-2021)
Figure 43. Latin America Biosimilar Drug Sales Market Share by Type (2016-2021)
Figure 44. Latin America Biosimilar Drug Sales Market Share by Application (2016-2021)
Figure 45. Middle East and Africa Biosimilar Drug Revenue Growth Rate 2016-2027 (US$ Million)
Figure 46. Middle East and Africa Biosimilar Drug Sales Market Share by Country (2016-2027)
Figure 47. Middle East and Africa Biosimilar Drug Revenue Market Share by Country (2016-2027)
Figure 48. Middle East and Africa Biosimilar Drug Sales Market Share by Type (2016-2021)
Figure 49. Middle East and Africa Biosimilar Drug Sales Market Share by Application (2016-2021)
Figure 50. Biosimilar Drug Supply Chain (Upstream and Downstream Market)
Figure 51. Global Production Market Share of Biosimilar Drug Raw Materials by Region in 2020
Figure 52. Biosimilar Drug Distribution Channels
Figure 53. Global Biosimilar Drug Percentage 2016-2027: Indirect Sales VS Direct Sales
Figure 54. Global Biosimilar Drug Percentage 2016-2027: Online Sales VS Offline Sales
Figure 55. Porter's Five Forces Analysis
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Biologics and Biosimilars Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 147

According to our LPI (LP Information) latest study, the global Biologics and Biosimilars market size was valued at US$ 458090 million in 2023. With growing demand in downstream market, the Biologics and Biosimilars is forecast to a readjusted size of US$ 837640 million by 2030 with a CAGR of 9.0% during review period. The research report highlights the growth potential of the global Biologics and Biosimilars market. Biologics and Biosimilars are expected to show stable growth in the futu......

Global Biosimilar Drug Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94

According to our LPI (LP Information) latest study, the global Biosimilar Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the Biosimilar Drug is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Biosimilar Drug market. Biosimilar Drug are expected to show stable growth in the future market. However, product differentiation, reducing cost......

Global Biologics and Biosimilars Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 147

According to our (Global Info Research) latest study, the global Biologics and Biosimilars market size was valued at USD 481830 million in 2023 and is forecast to a readjusted size of USD 842330 million by 2030 with a CAGR of 8.3% during review period. Biologics are very specific, highly effective medicines made in living cells, and historically this was often an animal. Biologics include hormones, cytokines, growth factors, vaccines, gene and cellular therapies, fusion proteins, insulin......

Global Biosimilars Market Research Report 2023, Forecast to 2028

Published: 27-Dec-2023        Price: US 2680 Onwards        Pages: 167

A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......

Global Biosimilars Professional Survey Report 2023, Forecast to 2028

Published: 27-Dec-2023        Price: US 3280 Onwards        Pages: 133

A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......

Global Biosimilars Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 07-Dec-2023        Price: US 3380 Onwards        Pages: 106

Market Overview of Global Biosimilars market: According to our latest research, the global Biosimilars market looks promising in the next 5 years. As of 2022, the global Biosimilars market was estimated at USD 8203.97 million, and it's anticipated to reach USD 40650.01 million in 2028, with a CAGR of 30.57% during the forecast years. A biosimilar product is a biologic product that is approved based on demonstrating that it is highly similar to an FDA?approved biologic product......

Global Biologics and Biosimilars Professional Survey Report 2023, Forecast to 2028

Published: 24-Nov-2023        Price: US 3280 Onwards        Pages: 134

Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......

Global Biologics and Biosimilars Market Research Report 2023, Forecast to 2028

Published: 24-Nov-2023        Price: US 2680 Onwards        Pages: 160

Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......

Global Biosimilar Monoclonal Antibodies Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 103

Market Overview of Global Biosimilar Monoclonal Antibodies market: According to our latest research, the global Biosimilar Monoclonal Antibodies market looks promising in the next 5 years. As of 2022, the global Biosimilar Monoclonal Antibodies market was estimated at USD 5156.19 million, and it's anticipated to reach USD 14274.14 million in 2028, with a CAGR of 18.5% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs